It's Not Over For Teva Just Yet After J-Code Rejection, Citi Says
April 20, 2016 at 11:47 AM EDT
The request by Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) for a separate J-code for Bendeka, the low-volume, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.